Moss Jeffrey D, Schwenk Hayden T, Chen Michael, Gaskari Shabnam
J Pediatr Pharmacol Ther. 2021;26(1):21-25. doi: 10.5863/1551-6776-26.1.21. Epub 2021 Jan 4.
Drug shortages have significantly affected the ability to provide care at pediatric institutions, particularly in the inpatient and critical care settings. The coronavirus disease 2019 (COVID-19) pandemic highlighted additional challenges with drug supply chains. A working group consisting of pharmacy management, clinical pharmacists, and pharmacy buyers met regularly at the beginning of the COVID-19 pandemic. In collaboration with medical staff leadership and the Pharmacy and Therapeutics Committee, we developed a pediatric critical drug list to track essential medications for targeted monitoring. We created an inventory model with easily modifiable input variables related to patient and hospital data. This model was aligned across affiliate health care systems to increase transparency of our hospital's surge capacity for managing patients with COVID-19. Here, we share our framework for modeling drug inventory management at a freestanding children's hospital during a global pandemic.
药品短缺严重影响了儿科机构提供护理的能力,尤其是在住院和重症监护环境中。2019年冠状病毒病(COVID-19)大流行凸显了药品供应链面临的更多挑战。在COVID-19大流行初期,一个由药房管理人员、临床药剂师和药房采购人员组成的工作组定期开会。我们与医务人员领导层以及药学与治疗学委员会合作,制定了一份儿科关键药物清单,以跟踪基本药物进行有针对性的监测。我们创建了一个库存模型,该模型具有与患者和医院数据相关的易于修改的输入变量。该模型在附属医疗系统中保持一致,以提高我们医院管理COVID-19患者的应急能力的透明度。在此,我们分享在全球大流行期间一家独立儿童医院的药品库存管理建模框架。